IL-2, Mouse (Biotinylated, HEK293, His-Avi)

[1]G Reya T, et al. Thymic stromal-cell abnormalities and dysregulated T-cell development in IL-2-deficient mice. Dev Immunol. 1998;5 (4) :287-302.|[2]Zhu J, et al. Stat5 activation plays a critical role in Th2 differentiation. Immunity. 2003 Nov;19 (5) :739-48.|[3]Smith GA, et al. Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling. Nat Chem Biol. 2016 May;12 (5) :373-9.|[4]Sim GC, et al. The IL-2 cytokine family in cancer immunotherapy. Cytokine Growth Factor Rev. 2014 Aug;25 (4) :377-90.|[5]Kim HP, et al. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006 Oct;17 (5) :349-66.|[6]Nelson BH. IL-2, regulatory T cells, and tolerance. J Immunol. 2004 Apr 1;172 (7) :3983-8.